Effect of troglitazone on exocrine pancreas in rats with streptozotocin-induced diabetes mellitus

Pancreas

Volumn 21, Issue 4, 2000, Pages 421-426

  Shimizu, Kyoko ^a   Shiratori, Keiko ^a   Hayashi, Naoaki ^a   Fujiwara, Toshihide ^b   Horikoshi, Hiroyoshi ^b  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b DAIICHI SANKYO CO   (Japan)

Author keywords

Diabetes mellitus; Exocrine pancreas; Insulin; Streptozotocin; Troglitazone

Indexed keywords

AMYLASE; CHOLECYSTOKININ OCTAPEPTIDE; GLUCOSE; INSULIN; PROTEIN; STREPTOZOCIN; TROGLITAZONE; TRYPSIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; EXOCRINE SECRETION; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; HYPERGLYCEMIA; HYPERINSULINEMIA; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MALE; NONHUMAN; ORGAN WEIGHT; PANCREAS; PANCREAS INSUFFICIENCY; PRIORITY JOURNAL; RAT;

ANIMALS; CHOLECYSTOKININ; CHROMANS; DIABETES MELLITUS, EXPERIMENTAL; GLUCOSE TOLERANCE TEST; HYPOGLYCEMIC AGENTS; INSULIN; MALE; PANCREAS; RATS; RATS, WISTAR; STREPTOZOCIN; THIAZOLES; THIAZOLIDINEDIONES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0033735280     PISSN: 08853177     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006676-200011000-00014     Document Type: Article

References (25)

1. Exocrine pancreatic function in juvenile-onset diabetes mellitus
2. External pancreatic secretion in diabetes mellitus
3. An important role of endogenous insulin on exocrine pancreatic secretion in rats
4. Mechanism of the action of insulin on pancreatic exocrine secretion in perfused rats pancreas
5. Characterization of new oral antidiabetic agent CS-045: Studies in KK and ob/ob mice and Zucker fatty rats
6. Characterization of CR-045, a new oral antidiabetic agent: II. Effects on glycemia control and pancreatic islet structure at a late stage of the diabetic syndrome in C57BL/KsJ-db/db mice
7. Prevention of hyperglycemia in the Zucker diabetic fatty rat by treatment with metformin or troglitazone
8. Metabolic effects of new oral hypoglycemia agent CS-045 in NIDDM subjects
9. Effect of troglitazone in insulin-treated patients with type II diabetes mellitus
10. Efficacy and metabolic effects of metformin and troglitazone in type II diabetes mellitus
11. The effect of acute hyperglycemia on meal-stimulated gastric, biliary, and pancreatic secretion, and serum gastrin
12. Troglitazone enhances differentiation, basal glucose uptake, and Glut1 protein levels in 3T3-L1 adipocytes
13. Antidiabetic thiazolidinediones block the inhibitory effect of tumor necrosis factor-α on differentiation, insulin-stimulated glucose uptake, and gene expression in 3T3-L1 cells
14. Protein measurement with the Folin phenol reagent
15. Pioglitazone increases insulin sensitivity by activating insulin receptor kinase
16. Troglitazone prevents glucose-induced insulin resistance of insulin receptor in rat-1 fibroblasts
17. Thiazolidine derivatives ameliorate high glucose-induced insulin resistance via the normalization of protein-tyrosine phosphatase activities
18. Insulin secretory defect in Zucker fa/fa rats in improved by ameliorating insulin resistance
19. Correction of hyperglycemia with phlorizin normalizes tissue sensitivity on insulin in diabetic rats
20. PPARγ tissue-specific regulator of an adipocyte enhancer
21. Peroxisome proliferator-activated receptor (PPARγ): Adipose-predominant expression and induction early in adipocyte differentiation
22. Altered gene expression for tumor necrosis factor-α and its receptors during drug and dietary modulation of insulin resistance
23. Effect of tumor necrosis factor on acetylco-enzyme A carboxylase gene expression and preadipocyte differentiation
24. Tumor necrosis factor-α- and hyperglycemia-induced insulin resistance: Evidence for different mechanisms and different effects on insulin signaling
25. Inhibition with N-acetylcysteine of enhanced production of tumor necrosis factor in streptozotocin-induced diabetic rats